Molecular subtyping of small cell lung cancer.

Abstract excerpt

Small cell lung cancer (SCLC), originating from lung neuroendocrine stem cells, is a common pulmonary malignant tumor. SCLC, with poor prognoses, accounts for approximately 13-15% of all lung cancer cases. Due to the slow progress of clinical treatment, the 5-year survival rate of SCLC has remained below 7% for many years. In recent years, with the development and popularity of gene sequencing technologies, we...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Lung Neoplasms
• Share to Mutation
• Share to Prognosis